Novel immunoenzymatic assay for identification of coagulase- and protein A-negative Staphylococcus aureus strains

9Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

A purified monoclonal antibody (MAb) which specifically reacts with Staphylococcus aureus glucosaminidase was obtained. This MAb was utilized to develop an immunoenzymatic assay for the identification of S. aureus strains. The sensitivity of this assay, based on the simultaneous detection of S. aureus glucosaminidase and protein A, was evaluated by analyzing a total of 196 strains, 26 of which did not exhibit one or more of the following properties: protein A, clumping factor, and staphylocoagulase. All strains yielded positive results by the MAb-based immunoenzymatic test. The assay's ability to differentiate between S. aureus and other staphylococci was then analyzed by testing a total of 277 non-S. aureus strains that yielded negative results. Our data demonstrate that this immunoenzymatic assay can be used as a single S. aureus identification criterion, particularly useful for those strains negative for clumping factor, staphylocoagulase, or protein A.

Cite

CITATION STYLE

APA

Guzman, C. A., Guardati, M. C., Fenoglio, D., Coratza, G., Pruzzo, C., & Satta, G. (1992). Novel immunoenzymatic assay for identification of coagulase- and protein A-negative Staphylococcus aureus strains. Journal of Clinical Microbiology, 30(5), 1194–1197. https://doi.org/10.1128/jcm.30.5.1194-1197.1992

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free